13F Holdings
中文EN

Atlas Venture Life Science Advisors, LLC

CAMBRIDGE MA · SEC CIK 0001917529

2026Q22026Q1 9 earlier quarters 🔒
$881.29M2026Q2 reported value
7Positions
100.0%Top 10 weight · largest 37.1%
0 / 0New / sold out
Reported value over time$881.29M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

KYMR 37.1%
DYN 17.1%
SION 15.0%
KLRA 12.9%
IRON 12.6%
QTTB 3.9%
KRRO 1.4%

2026Q2 top buys estimated at quarter-end value

QTTB Added+$7.96M

2026Q2 top sells estimated at quarter-end value

KYMR Reduced-$198.43M
DYN Reduced-$51.76M
KRRO Reduced-$2.30M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
KYMR Kymera Therapeutics, Inc. $326.53M37.05%2,847,541 -1,730,467-37.8% -$198.43M Reduced
DYN Dyne Therapeutics, Inc. $151.03M17.14%6,800,099 -2,330,366-25.5% -$51.76M Reduced
SION Sionna Therapeutics, Inc. $131.78M14.95%2,995,602 00.0% — Unchanged
KLRA Kailera Therapeutics, Inc. $113.92M12.93%5,171,282 5,171,282— — First reported
IRON Disc Medicine, Inc. $110.72M12.56%1,513,875 00.0% — Unchanged
QTTB Q32 Bio, Inc. $34.62M3.93%2,717,106 625,00029.9% $7.96M Added
KRRO Korro Bio, Inc. $12.69M1.44%962,884 -174,265-15.3% -$2.30M Reduced